Pharmaceutical

Summary

  • Publication date: August 2009

Introduction Following the patent expiries of angiotensin-II receptor blockers Datamonitor expects antihypertensives sales in the seven major industry s to record sales of USD 29.5 billion in 2018, a drop of over USD 6 billion compared to 2008. Why Should You Buy This Report? *Quantify the future size of the antihypertensives industry and identify areas of growth for new products. *Learn how recent changes related to ...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Share

Pharmaceutical Industry : Latest Reports

Alzheimer disease - New drugs, markets and companies

Alzheimer disease - New drugs, markets and companies

  • $ 3 500
  • Industry report
  • February 2012
  • by Jain PharmaBiotech

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable ...

Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion

Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion

  • $ 3 500
  • Industry report
  • March 2012
  • by GBI Research

Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion Summary GBI Research, the leading business intelligence provider, ...

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution

  • $ 3 500
  • Industry report
  • May 2012
  • by GBI Research

Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution Summary GBI Research, the leading business ...

Generic Drugs: The Global Market

September 2011 $ 4 850

Vaccines - Global

March 2012 $ 26 587

Pharmaceutical Industry : Latest Downloads

Hypertension Industry Overview (hypertension, atherosclerosis, stroke)

Hypertension Industry Overview (hypertension, atherosclerosis, stroke)

  • Industry report
  • April 2012
  • 35 pages

... Beverages, and juices hypertension hypertension is defined as a systolic blood pressure (sbp) of 140 mm hg or greater, a diastolic blood (dbp) of 90 mm hg or greater, or taking antihypertensive ...

Atorvastatin Sector Brief

Atorvastatin Sector Brief

  • Industry report
  • April 2012
  • 19 pages

... For ease of swallowing and not to divide into equal doses. 4. Clinical particulars 4.1 Therapeutic indications hypercholesterolaemia atorvastatine mylan is indicated as an adjunct to diet for reduction ...

Drug Discovery : Innovation and Technology Trends

Drug Discovery : Innovation and Technology Trends

  • Industry report
  • February 2012
  • 5 pages

... For therapeutic efficacy. Natural products still play a major role as starting materials for drug discovery. According to a report published in 2007 that covers drug development between 1981 and 2006, of 974 ...


Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.